 We all have the challenges of cancer and all these things. Why wouldn't we just try to make it universal? Like you said, we're trying to do that with metadoxin and NFT. And in the same capacity, XCURES is actually the company that had me stumble upon what they're doing and this podcast is they're trying to do the same thing. They're like, stop having these focalities of like, this is the company that'll do this study and this one will do this one. Instead, they're like, let's just aggregate everything. We're humankind. What is happening in patients that have these mutations and do they make your chance of breast cancer higher? Did they play a role in your breast cancer? If you could just aggregate all of the oncologist information and we have AI that can do all this in like a gazillion speed that we can, that's the quickest way we push things in cancer management and understanding. It's just to come together.